No Sass files were modified. Time elapsed 0.0011 seconds

Modification of escalated beacopp with dacarbazine / procarbazine substitution reduces red cell transfusion requirements and may shorten time to menstrual period recovery


  • Haematology


Document Type

Published Date

  • 2019-06


  • It is increasingly common practice to modify escalated BEACOPP (eBPP) by removing oral procarbazine and replacing with intravenous dacarbazine (250mg/m2 D2‐3), hoping to reduce haematopoietic stem cell and gonadal toxicity. However, published data on the so‐called ‘escalated BEACOPDac (eBPDac)’ regimen are limited.
Back to Top